Mendaera

Executive Summary

Mendaera is a medical device company pioneering the Focalist System, a handheld robotic platform that enhances precision in ultrasound-guided needle-based procedures. By integrating robotics with real-time imaging, the system aims to improve procedural accuracy and reproducibility, addressing a critical need in interventional medicine. Founded in 2018 and based in Redwood City, California, Mendaera has already received FDA clearance and is preparing for a broad commercial launch in 2026. The company's technology simplifies complex clinical tasks, potentially reducing variability and improving outcomes across various specialties. With a clear regulatory path and a focus on a large addressable market (e.g., biopsies, drainages, injections), Mendaera is well-positioned for growth. The upcoming commercial rollout will be a key milestone, testing the product's market acceptance and Mendaera's ability to scale manufacturing and sales.

Upcoming Catalysts (preview)

• 2026Broad commercial launch of Focalist System80% success